Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease

Name: Tislelizumab in Combination With Bevacizumab and Capecitabine in Advanced Solid Tumors With Evaluation in Immunotherapy-Resistant and Central Nervous System Disease
License: Public Domain

National University Hospital, Singapore

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

breastcancer

advanced solid tumor cancer, triple-negative breast cancer (tnbc), cns disease, breast cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 633737
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.